Loading...
Chemical structure of Ubrogepant

GC30341

Ubrogepant

Also listed as Ubrogepant (MK-1602)

Ubrogepant (MK-1602) (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine

ChemicalCAS1374248-77-7MW549.54FormulaC29H26F3N5O3
CAS number
1374248-77-7
Molecular weight
549.54
Formula
C29H26F3N5O3
Solubility
DMSO ： 250 mg/mL (454·93 mM; Need ultrasonic)
InChIKey
DDOOFTLHJSMHLN-ZQHRPCGSSA-N
Catalogue number
GC30341
Brand
GLPBIO
Computed properties PubChem CID 68748835 · XLogP 3.1 · TPSA 104 Ų · H-bond donors 2
XLogP
3.1
TPSA
104 Ų
H-bond donors
2
H-bond acceptors
8
Rotatable bonds
4
Heavy atoms
40

SMILES C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6

Computed descriptors from PubChem (CID 68748835), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.